Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial

被引：0

作者：

Toshihiko Doi

Tetsuya Hamaguchi

Kuniaki Shirao

Kensho Chin

Kiyohiko Hatake

Kazuo Noguchi

Tetsuya Otsuki

Anish Mehta

Atsushi Ohtsu

机构：

[1] National Cancer Center Hospital East,

[2] National Cancer Center,undefined

[3] Oita University,undefined

[4] Cancer Institute Hospital of Japanese Foundation for Cancer Research,undefined

[5] MSD K.K.,undefined

[6] Merck Sharpe & Dohme Corp,undefined

来源：

International Journal of Clinical Oncology | 2013年 / 18卷

关键词：

Histone deacetylase inhibitor (HDACi); Gastrointestinal cancer; Vorinostat; Suberoylanilide hydroxamic acid (SAHA);

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：87 / 95

页数：8

共 83 条